Streetbeat News

BIOYF

Biosyent Inc

Industry

Medicinal and Botanical Manufacturing

Open

8.16

Mkt cap

95M

Volume

500

High

8.16

P/E Ratio

19.43

52-wk high

8.90

Low

8.16

Div yield

0.02

52-wk low

5.93

BioSyent Inc. has announced the renewal of its Normal Course Issuer Bid, allowing the company to repurchase up to 690,000 of its common shares over the next 12 months, representing about 6.07% of its outstanding shares.

Portfolio Pulse from

December 16, 2024 | 1:45 pm

BioSyent Inc. released its financial results for Q3 and YTD 2024, highlighting key performance metrics.

Portfolio Pulse from

November 20, 2024 | 1:15 pm

BioSyent Inc. has declared a quarterly dividend of $0.045 per common share for the fourth quarter of 2024, payable on December 16, 2024. The dividend remains unchanged from the previous quarter.

Portfolio Pulse from

November 20, 2024 | 1:15 pm

BioSyent Inc. will release its Q3 and YTD 2024 financial results on November 20, 2024. The results will be available before market opening, and a presentation by the CEO will be accessible on the company's website.

Portfolio Pulse from

November 13, 2024 | 9:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.